FI94637B - Framställning av 2,6-dioxopiperidinderivat - Google Patents
Framställning av 2,6-dioxopiperidinderivat Download PDFInfo
- Publication number
- FI94637B FI94637B FI904673A FI904673A FI94637B FI 94637 B FI94637 B FI 94637B FI 904673 A FI904673 A FI 904673A FI 904673 A FI904673 A FI 904673A FI 94637 B FI94637 B FI 94637B
- Authority
- FI
- Finland
- Prior art keywords
- reaction
- process according
- alkyl
- potassium
- carbon atoms
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 11
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N piperidine-2,6-dione Chemical class O=C1CCCC(=O)N1 KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 125000004432 carbon atom Chemical group C* 0.000 claims description 21
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 19
- 238000005804 alkylation reaction Methods 0.000 claims description 17
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical group [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 14
- -1 fluoroalkyl halide Chemical class 0.000 claims description 13
- 230000029936 alkylation Effects 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 239000011698 potassium fluoride Substances 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 6
- 150000004703 alkoxides Chemical class 0.000 claims description 5
- 125000005907 alkyl ester group Chemical group 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 4
- PAEXAIBDCHBNDC-UHFFFAOYSA-N 2-pyridin-4-ylacetic acid Chemical class OC(=O)CC1=CC=NC=C1 PAEXAIBDCHBNDC-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000908 ammonium hydroxide Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims description 3
- 235000003270 potassium fluoride Nutrition 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000003586 protic polar solvent Substances 0.000 claims description 2
- BPSNETAIJADFTO-UHFFFAOYSA-N 2-pyridinylacetic acid Chemical compound OC(=O)CC1=CC=CC=N1 BPSNETAIJADFTO-UHFFFAOYSA-N 0.000 claims 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 230000001351 cycling effect Effects 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Natural products CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 17
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- QXKJWHWUDVQATH-UHFFFAOYSA-N rogletimide Chemical compound C=1C=NC=CC=1C1(CC)CCC(=O)NC1=O QXKJWHWUDVQATH-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- QVLJLWHOILVHJJ-UHFFFAOYSA-N ethyl 2-pyridin-4-ylacetate Chemical compound CCOC(=O)CC1=CC=NC=C1 QVLJLWHOILVHJJ-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 235000019439 ethyl acetate Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 5
- 125000003368 amide group Chemical group 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 125000004093 cyano group Chemical group *C#N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000007363 ring formation reaction Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000012299 nitrogen atmosphere Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- RHLWQEFHFQTKNT-UHFFFAOYSA-N (2z)-1-cyclooctyl-2-diazocyclooctane Chemical compound [N-]=[N+]=C1CCCCCCC1C1CCCCCCC1 RHLWQEFHFQTKNT-UHFFFAOYSA-N 0.000 description 2
- UWLHSHAHTBJTBA-UHFFFAOYSA-N 1-iodooctane Chemical compound CCCCCCCCI UWLHSHAHTBJTBA-UHFFFAOYSA-N 0.000 description 2
- BMVSAKPRNWZCPG-UHFFFAOYSA-N 2-pyridin-4-ylacetonitrile Chemical compound N#CCC1=CC=NC=C1 BMVSAKPRNWZCPG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 101001108356 Homo sapiens Nardilysin Proteins 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 102100021850 Nardilysin Human genes 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- OBPGGDQYOLIFIL-UHFFFAOYSA-N 1-pyridin-4-ylpiperidine-2,6-dione Chemical compound O=C1CCCC(=O)N1C1=CC=NC=C1 OBPGGDQYOLIFIL-UHFFFAOYSA-N 0.000 description 1
- MXNNUYDUWHPTRU-UHFFFAOYSA-N 3-octyl-3-pyridin-4-ylpiperidine-2,6-dione Chemical compound C=1C=NC=CC=1C1(CCCCCCCC)CCC(=O)NC1=O MXNNUYDUWHPTRU-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 159000000006 cesium salts Chemical class 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- GHLZUHZBBNDWHW-UHFFFAOYSA-N nonanamide Chemical class CCCCCCCCC(N)=O GHLZUHZBBNDWHW-UHFFFAOYSA-N 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000012485 toluene extract Substances 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (9)
1. Förfarande för framställning av 3-alkyl- eller -fluoralkyl-3-(4-pyridyl)piperidin-2,6-dioner med formeln (1) r^H/Λ n,
0 N Ό H väri R betecknar en alkylgrupp med 2-10 kolatomer eller en fluoralkylgrupp med 2-5 kolatomer, och A betecknar väte eller en alkylgrupp med 1-4 kolatomer, utgäende frän ett 4-pyridylättik-syraderivat, kannetecknat av att en alkylester av 4-pyridylät-tiksyra med formeln (4) -O (4) VRS väri R5 betecknar en alkylgrupp och symbolen A har ovan angivna betydelse, alkyleras med en alkyl- eller fluoralkylhalogenid enligt formeln RX, varvid symbolen X betecknar jod, brom eller klor, i närvaro av en steriskt bulkig bas av en natrium-, ka-lium- eller ammoniumkatjon, varefter produkten frän denna alky-leringsreaktion omsättes med akrylamid i närvaro av en grenad natrium- eller kaliumalkoxid tills cykliseringen sker.
2. Förfarande enligt patentkrav l, kännetecknat av att alkyle-ringsreaktionen genomförs i närvaro av (a) en grenad natrium-eller kaliumalkoxid eller kvaternär ammoniumhydroxid eller (b) kaliumfluorid bunden vid aluminiumoxid.
3. Förfarande enligt patentkrav 1, kännetecknat av att bäde alkyleringsreaktionen och reaktionen med akrylamid genomförs i närvaro av ett natrium- eller kaliumsalt av en grenad alkoxid ·· med 3-5 kolatomer. 16 -.94637
4. Förfarande enligt patentkrav 3, kännetecknat av att den grenade alkoxiden utgörs av kalium-t-butoxid.
5. Förfarande enligt patentkrav 3 eller 4, kännetecknat av att alkyleringen och reaktionen med akrylamid genomförs successivt i samma reaktionskärl.
6. Förfarande enligt patentkrav 3, 4 eller 5, kännetecknat av att alkyleringen och reaktionen med akrylamid genomförs vid rumstemperatur i en alkohol eller ett polärt icke-protiskt lösningsmedel.
7. Förfarande enligt ndgot av föregäende patentkrav, känne-tecknat av att R betecknar en alkylgrupp med 2-8 kolatomer.
8. Förfarande enligt nägot av föregäende patentkrav, kanne-tecknat av att X betecknar jod.
9. Förfarande enligt patentkrav 8, kännetecknat av att i alky-leringsreaktionen basen upplöses i 4-pyridylättiksyraestern och jodiden tillsättes denna lösning. • · f « « «
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8806751 | 1988-03-22 | ||
| GB888806751A GB8806751D0 (en) | 1988-03-22 | 1988-03-22 | Preparation of 2 6-dioxopiperidine derivatives |
| GB888825501A GB8825501D0 (en) | 1988-11-01 | 1988-11-01 | Improvements relating to preparation of 2 6-dioxopiperidine derivatives |
| GB8825501 | 1988-11-01 | ||
| PCT/GB1989/000308 WO1989009216A1 (en) | 1988-03-22 | 1989-03-22 | Preparation of 2,6-dioxopiperidine derivatives |
| GB8900308 | 1989-03-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI904673A0 FI904673A0 (sv) | 1990-09-21 |
| FI94637B true FI94637B (sv) | 1995-06-30 |
| FI94637C FI94637C (sv) | 1995-10-10 |
Family
ID=26293668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI904673A FI94637C (sv) | 1988-03-22 | 1990-09-21 | Framställning av 2,6-dioxopiperidinderivat |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5112976A (sv) |
| EP (1) | EP0334633B1 (sv) |
| JP (1) | JPH03503891A (sv) |
| KR (1) | KR920003803B1 (sv) |
| AU (1) | AU621602B2 (sv) |
| CA (1) | CA1335290C (sv) |
| DE (1) | DE68906449T2 (sv) |
| DK (1) | DK171067B1 (sv) |
| FI (1) | FI94637C (sv) |
| GB (1) | GB2216524B (sv) |
| IE (1) | IE64347B1 (sv) |
| IL (1) | IL89631A (sv) |
| NO (1) | NO176211C (sv) |
| WO (1) | WO1989009216A1 (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9602516D0 (en) * | 1996-02-08 | 1996-04-10 | Chiroscience Ltd | Racemisation |
| KR970061867A (ko) * | 1996-02-23 | 1997-09-12 | 박민수 | 글루탐산 유도체, 그의 약제학적으로 허용가능한 염 및 이를 유효성분으루 함유하는 항경련제 |
| US9777116B2 (en) | 2014-10-16 | 2017-10-03 | International Business Machines Corporation | Porous/nanoporous PHT |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2673205A (en) * | 1951-02-13 | 1954-03-23 | Ciba Pharm Prod Inc | 3-disubstituted dioxopiperidines and the manufacture thereof |
| US2848455A (en) * | 1955-07-18 | 1958-08-19 | Ciba Pharm Prod Inc | Alpha-(p-amino-phenyl)-alpha-lower alkyl glutarimides |
| GB2151226B (en) * | 1983-12-09 | 1987-04-01 | Nationl Research Dev Corp | 2, 6-dioxopiperidine derivatives, their preparation and pharmaceutical compositions containing them |
| GB8332954D0 (en) * | 1983-12-09 | 1984-01-18 | Foster A B | A 2,6-dioxopiperidine derivative and pharmaceutical compositions |
| US4668689A (en) * | 1984-07-19 | 1987-05-26 | National Research Development Corporation | Glutarimide derivatives for treating oestrogen-dependent tumors |
-
1989
- 1989-03-16 IL IL89631A patent/IL89631A/xx not_active IP Right Cessation
- 1989-03-20 IE IE86789A patent/IE64347B1/en not_active IP Right Cessation
- 1989-03-21 CA CA000594265A patent/CA1335290C/en not_active Expired - Fee Related
- 1989-03-22 AU AU33458/89A patent/AU621602B2/en not_active Ceased
- 1989-03-22 EP EP89302841A patent/EP0334633B1/en not_active Expired - Lifetime
- 1989-03-22 GB GB8906580A patent/GB2216524B/en not_active Expired - Lifetime
- 1989-03-22 WO PCT/GB1989/000308 patent/WO1989009216A1/en not_active Ceased
- 1989-03-22 DE DE8989302841T patent/DE68906449T2/de not_active Expired - Fee Related
- 1989-03-22 KR KR1019890003564A patent/KR920003803B1/ko not_active Expired
- 1989-03-22 JP JP1503628A patent/JPH03503891A/ja active Pending
- 1989-05-10 US US07/701,641 patent/US5112976A/en not_active Expired - Fee Related
-
1990
- 1990-09-20 NO NO904108A patent/NO176211C/no unknown
- 1990-09-21 FI FI904673A patent/FI94637C/sv not_active IP Right Cessation
- 1990-09-21 DK DK228990A patent/DK171067B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK228990D0 (da) | 1990-09-21 |
| WO1989009216A1 (en) | 1989-10-05 |
| EP0334633A1 (en) | 1989-09-27 |
| DK228990A (da) | 1990-09-21 |
| IL89631A0 (en) | 1989-09-10 |
| US5112976A (en) | 1992-05-12 |
| JPH03503891A (ja) | 1991-08-29 |
| DE68906449T2 (de) | 1993-09-02 |
| IE890867L (en) | 1989-09-22 |
| NO904108L (no) | 1990-09-20 |
| FI94637C (sv) | 1995-10-10 |
| FI904673A0 (sv) | 1990-09-21 |
| IE64347B1 (en) | 1995-07-26 |
| AU621602B2 (en) | 1992-03-19 |
| DK171067B1 (da) | 1996-05-20 |
| NO176211B (no) | 1994-11-14 |
| DE68906449D1 (de) | 1993-06-17 |
| EP0334633B1 (en) | 1993-05-12 |
| GB8906580D0 (en) | 1989-05-04 |
| NO176211C (no) | 1995-02-22 |
| GB2216524A (en) | 1989-10-11 |
| KR890014518A (ko) | 1989-10-24 |
| KR920003803B1 (ko) | 1992-05-15 |
| IL89631A (en) | 1993-05-13 |
| GB2216524B (en) | 1991-06-12 |
| NO904108D0 (no) | 1990-09-20 |
| CA1335290C (en) | 1995-04-18 |
| AU3345889A (en) | 1989-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU189738B (en) | Process for preparing intermediary compounds of omeprazole | |
| JPS60132968A (ja) | β‐ヒドロキシエチル‐（１，２，４‐トリアゾール）誘導体の製法 | |
| FI94637B (sv) | Framställning av 2,6-dioxopiperidinderivat | |
| NO783559L (no) | Fremgangsmaate til fremstilling av 2,6-diaminonebulariner | |
| CA1082198A (en) | Process for preparation of a therapeutically active compound | |
| Odijk et al. | Fluorescent nucleoside analogues: synthesis of fluorescent pyrido [2, 1-i] purines, and their corresponding ribosides | |
| RU2254334C2 (ru) | Способ получения 6-метил-2-(4-метилфенил)-имидазоло[1,2-а]-пиридин-3-(n, n-диметилацетамида), эфиры, кристаллические эфиры, способ их получения | |
| JP4742868B2 (ja) | （２ｒ）−２−プロピルオクタン酸の製造方法、その中間体 | |
| IE51960B1 (en) | Process for the preparation of quinolin-4-ones | |
| US4189444A (en) | Process for the preparation of N,N'-disubstituted 2-naphthaleneethanimidamide and intermediates used therein | |
| EP0812828B1 (en) | Process for the preparation of (5,6-dicarboxy-3-pyridyl) methyl ammonium halides | |
| EP1471058B1 (en) | Process for producing 1,2,3-triazole compound | |
| JP2659587B2 (ja) | ４―アジリジニルピリミジン誘導体及びその製造法 | |
| IE59893B1 (en) | Process for the manufacture of n-(sulfonylmethyl) formamides | |
| EP0464218B1 (en) | Process for producing isoxazole derivative | |
| US6096894A (en) | Production method of 2-(p-alkylphenyl)pyridine compound | |
| KR100311949B1 (ko) | 1-[(사이클로펜트-3-엔-1-일)메틸]-5-에틸-6-(3,5-다이메틸벤조일)-2,4-피리미딘다이온의제조방법 | |
| JP4165110B2 (ja) | ４−オキシピリミジン誘導体の製法 | |
| Takahashi et al. | SYNTHESIS OF 3‐SUBSTITUTED 5, 6‐DIPHENYLPYRIMIDIN‐4‐ONES FROM DIPHENYLCYCLOPROPENONE AND N‐SUBSTITUTED AMIDE OXIMES | |
| JPH0692988A (ja) | ２，２′−アンヒドロアラビノシルチミン誘導体の合成法 | |
| SU334838A1 (ru) | Способ получени @ -арил- @ -алкиламидоалкил (хлоралкил) тиофосфонатов,содержащих в арильном радикале алкилгалоид-или алкилнитро-,или галоиднитро-,или нитрогруппу | |
| JPH0741479A (ja) | ７−アザプテリジン類およびその製造方法 | |
| JPH0234943B2 (sv) | ||
| JPH04996B2 (sv) | ||
| JPH04300856A (ja) | ３−ｎ−アルコキシアルキル−ｎ−アルキルアミノフェノール誘導体の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: BRITISH TECHNOLOGY GROUP LIMITED |
|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: BRITISH TECHNOLOGY GROUP LTD |